Nanocan Therapeutics

About:

Nanocan Therapeutics provides medicines and other products intended to patients with certain cancers, respiratory tract infections.

Website: http://www.nanocan.life/

Description:

Nanocan Therapeutics provides medicines and other products intended to patients with certain cancers, respiratory tract infections. The company leverages nanotechnology to create solutions for hard-to-cure indications where current interventions are insufficient. Through the application of nanotechnology to medicine, Nanocan aims to help improve the quality of life of our patients, increase access to medicine and other treatments, and to reduce global health disparities.

Total Funding Amount:

$1.13M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Princeton, New Jersey, United States

Founded Date:

2020-01-01

Founders:

Eric Broyles, Jacques P. Walker

Number of Employees:

1-10

Last Funding Date:

2020-08-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai